ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

Tobacco Council Awards 34 New Grants

April 16, 1982

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

October 21, 1977

Beckman Coulter Offers Immunoassay System.

July 27, 2001

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014